Loading...
•
Jun 30, 2020
Amphastar Q2 2020 Earnings Report
Reported net revenues of $85.8 million and a GAAP net loss of $0.2 million.
Key Takeaways
Amphastar Pharmaceuticals reported net revenues of $85.8 million for the three months ended June 30, 2020. The company reported a GAAP net loss of $0.2 million, or $0.00 per share, and an adjusted non-GAAP net income of $7.6 million, or $0.16 per share.
Net revenues for the second quarter were $85.8 million.
GAAP net loss for the second quarter was $0.2 million, or $0.00 per share.
Adjusted non-GAAP net income for the second quarter was $7.6 million, or $0.16 per share.
Primatene® Mist and epinephrine multi-dose vial launch performed strongly.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...